03514oam 2200661I 450 991046347880332120170816153623.01-317-73375-41-315-79085-81-317-73376-210.4324/9781315780855 (CKB)2670000000518878(EBL)1619373(SSID)ssj0001174272(PQKBManifestationID)11977475(PQKBTitleCode)TC0001174272(PQKBWorkID)11107689(PQKB)10820300(OCoLC)874172833(MiAaPQ)EBC1619373(OCoLC)897457634(EXLCZ)99267000000051887820180706d2013 uy 0engur|n|---|||||txtccrInternational strategy and market performance in new biotechnology firms /Joseph E. CoombsNew York :Routledge,2013.1 online resource (111 p.)Transnational business and corporate cultureDescription based upon print version of record.1-138-97293-2 0-8153-3501-6 Includes bibliographical references and index.Cover; Transnational Business and Corporate Culture; Title Page; Copyright Page; Dedication; Table of Contents; Preface; Acknowledgments; List of Tables and Figures; Chapter 1 Introduction; Chapter 2 Theory and Hypotheses; Biotechnology Research; Literature Review: International Entrepreneurship; Literature Review: Organizational Change; Hypotheses; Chapter 3 Methodology; Research Design; Sample Selection; Measures of Constructs, Model I; Measures of Constructs, Model II; Measures of Constructs, Model III; Chapter 4 Analysis and Results; Data Analysis; Descriptive StatisticsDirection of Change in International StrategyForeign Revenue as a Percentage of Total Revenue; Firm Market Value; Chapter 5 Discussion and Conclusions; Discussion of Results; Limitations of the Study; Future Research; Appendix A Firms Included in Study; Appendix B Sample Coding Sheet; References; IndexThe issues addressed in this study are: What internal factors support changes in the international operations of new firms? and What effect do these changes have on the firm's structure, control system, and market performance.To answer these questions, this work examines the internal resources and market performance of a set of publicly traded biotechnology firms. Findings support the view that new firms can enter international markets through a variety of strategies, including international joint ventures and subsidiaries. Changes in international operations also are found to enhance firmTransnational Business and Corporate CultureBiotechnology industriesNew business enterprisesInternational business enterprisesInternational tradeElectronic books.Biotechnology industries.New business enterprises.International business enterprises.International trade.338.4/76606Coombs Joseph E.1966-,932476MiAaPQMiAaPQMiAaPQBOOK9910463478803321International strategy and market performance in new biotechnology firms2098380UNINA